Title {1}	Azithromycin added to hydroxychloroquine in patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—randomised controlled trial AZIQUINE-ICU
Trial registration {2a and 2b}.	Clinical trials.gov: NCT04339816 Eudra CT number: 2020-001456-18
Protocol version {3}	AZIQUINE-ICU 25032020 Version 1.5
Funding {4}	The trial is funded by Donatio Intensivistam Endowment Fund www.donatio-intensivistam.cz, VAT No 0907206 Registered under No N1795 by Municipal Court in Prague on 2 April 2020, trial drugs were provided as a kind gift of Zentiva, a.s. and a rapid grant from COVID-19 GAMA-2 scheme of Technology Agency of the Czech Republic
Author details {5a}	• František Duška, Milada Halačová, Petr Waldauf, Anne Le Roy, Irena Kozáková, Viktor Kubricht, Veronika Řehořová from Dept. of Anaesthesia and Intensive Care Charles University, 3rd Faculty of Medicine and FNKV University Hospital, Prague, Czech Republic • Jakub Bala, Na Bulovce Hospital, Prague, Czech Republic • Martin Balík, Charles University, 1st Faculty of Medicine and VFN University Hospital Prague, Czech Republic • Jan Beneš, Charles University, Medical Faculty and University Hospital Plzen, Czech Republic • Olga Klementová, Medical Faculty, Palacky University and Olomouc University Hospital, Czech Republic • Tomáš Vymazal, Charles University, 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic • Václav Zvoníček, Masaryk University, Medical Faculty and U Svate Anny University Hospital, Brno, Czech Republic • Vladimír Černý from Czech Anaesthesia Clinical Trials and Audit Network and Dept. of Anaesthesia and Intensive Care, Masaryk’s Hospital, Ústí nad Labem, Czech Republic
Name and contact information for the trial sponsor {5b}	Donatio Intensivistam Endowment Fund VAT No 0907206 Registered under No N1795 by Municipal Court in Prague on 2 April 2020. Address: Hornoměcholupská 40c/1640, 10200 Prague 15, Czech Republic www.donatio-intensivistam.cz, František Duška, MD, PhD, founder Email: frantisek.duska@lf3.cuni.cz Phone: +420608405541
Role of sponsor {5c}	This is an investigator-initiated study. Study funders had no role in the study design; collection, management, analysis, and interpretation of data; nor in writing of the report or the decision to submit the report for publication.